top of page

Positive Phase I data for IMCgp100 in metastatic melanoma

Immunocore has announced positive data from the first in human, Phase I clinical trial of its lead ImmTAC (Immune mobilising monoclonal TCRs Against Cancer), IMCgp100.

Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/41509/news/industry-news/imcgp100-melanoma/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page